I
About
ImmunoScape is a biotechnology company focused on developing novel immunotherapies and diagnostics for cancer. They leverage their proprietary platform to identify and target key immune pathways involved in cancer progression and treatment response. The company is actively pursuing clinical trials to validate their therapeutic candidates.
Technology stack
detected 2026-06-14Est. monthly stack spend~$360/mo
CDN
Cloudflare
Email
Google Workspace
Stack
jQuery
WordPress
Analytics
Google Tag Manager
SEO
Rank Math
Compliance
GDPR
CCPA
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does ImmunoScape do?
ImmunoScape is a biotechnology company focused on developing novel immunotherapies and diagnostics for cancer. They leverage their proprietary platform to identify and target key immune pathways involved in cancer progression and treatment response. The company is actively pursuing clinical trials to validate their therapeutic candidates.
How much funding has ImmunoScape raised?
ImmunoScape has raised a total of $50M in funding. The most recent round on record is Series B2.
Where is ImmunoScape headquartered?
ImmunoScape is headquartered in Singapore, Singapore.
When was ImmunoScape founded?
ImmunoScape was founded in 2017.
What industry does ImmunoScape operate in?
ImmunoScape operates in Biotechnology, Cancer, Immunotherapy, Diagnostics.